Strontium Ranelate 8H2O
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Strontium Ranelate 8H2O Product Information
Strontium Ranelate 8H2O is listed under Intermediate and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Strontium. The product is supplied by Clearsynth under CAT No. CS-O-02383.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Strontium Ranelate 8H2O
CAS No.
10378-48-0
CAT No.
CS-O-02383
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C12H22N2O16SSr2
Molecular Weight
657.61
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Strontium Ranelate 8H2O is supplied with detailed characterization data compliant with regulatory guideline. Strontium Ranelate 8H2O can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Strontium.
Overview
"Strontium ranelate is an antiosteoporotic agent which both increases bone formation and reduces bone resorption, resulting in a rebalance of bone turnover in favor of bone formation."
Synonyms
Strontium Ranelate 8H2O
Application Notes
"Strontium ranelate is an antiosteoporotic agent which both increases bone formation and reduces bone resorption, resulting in a rebalance of bone turnover in favor of bone formation."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.